Literature DB >> 1632771

Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices.

R Gyurko1, B Kimura, P Kurian, F T Crews, M I Phillips.   

Abstract

Among the many functions of angiotensin II (Ang II) it now appears that Ang II is a growth factor. The concentration of Ang II in rat skin has been shown to increase during wound healing. To investigate the intracellular effect of Ang II in skin we determined the levels of total cytoplasmic inositol phosphates after incubation of skin slices with different doses of Ang II. 10(-6) M of Ang II increased significantly the phosphatidylinositol (PI) hydrolysis, and the effect was dose dependent up to 10(-4) M Ang II. The majority of inositol phosphates yielded after 1 hour incubation in the presence of lithium was InsP1, with lesser amount of InsP2. Losartan, the Ang II AT1 antagonist, at a dose of 10(-4) M blocked the effect of Ang II, while PD123319, the Ang II AT2 antagonist, had no antagonistic action; PD123319 at the higher dose of 10(-3) M, however, potentiated the effect of Ang II on PI hydrolysis. The results suggest that PI hydrolysis is a second messenger system for Ang II in rat skin. Also, the two subtypes of Ang II receptors mediate opposite effects on PI hydrolysis: Ang II binding to AT1 receptors increases inositol phosphate production, while Ang II binding to AT2 receptors decreases inositol phosphate production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632771     DOI: 10.1016/s0006-291x(05)80805-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Effects of angiotensin II receptor signaling during skin wound healing.

Authors:  Hikaru Takeda; Yohtaro Katagata; Yutaka Hozumi; Shigeo Kondo
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

2.  Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia.

Authors:  Cristina Nogueira-Silva; Emanuel Carvalho-Dias; Paulina Piairo; Susana Nunes; Maria J Baptista; Rute S Moura; Jorge Correia-Pinto
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 4.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

5.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Authors:  M Nakajima; H G Hutchinson; M Fujinaga; W Hayashida; R Morishita; L Zhang; M Horiuchi; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.

Authors:  Y A Lee; C S Liang; M A Lee; K Lindpaintner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall.

Authors:  Koichi Suzuki; Gi Dong Han; Naoko Miyauchi; Taeko Hashimoto; Takeshi Nakatsue; Yumiko Fujioka; Hiroko Koike; Fujio Shimizu; Hiroshi Kawachi
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

8.  Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans.

Authors:  R D Ramracheya; D S Muller; Y Wu; B J Whitehouse; G C Huang; S A Amiel; J Karalliedde; G Viberti; P M Jones; S J Persaud
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.